Wonkyung Byon

2.3k total citations · 1 hit paper
29 papers, 1.7k citations indexed

About

Wonkyung Byon is a scholar working on Cardiology and Cardiovascular Medicine, Internal Medicine and Pharmacology. According to data from OpenAlex, Wonkyung Byon has authored 29 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Cardiology and Cardiovascular Medicine, 9 papers in Internal Medicine and 7 papers in Pharmacology. Recurrent topics in Wonkyung Byon's work include Atrial Fibrillation Management and Outcomes (15 papers), Venous Thromboembolism Diagnosis and Management (9 papers) and Pharmacogenetics and Drug Metabolism (7 papers). Wonkyung Byon is often cited by papers focused on Atrial Fibrillation Management and Outcomes (15 papers), Venous Thromboembolism Diagnosis and Management (9 papers) and Pharmacogenetics and Drug Metabolism (7 papers). Wonkyung Byon collaborates with scholars based in United States, Germany and Sweden. Wonkyung Byon's co-authors include Charles Frost, Rebecca A. Boyd, Frank LaCreta, Jessie Wang, Andrew Shenker, Samira M. Garonzik, Zhigang Yu, Yu Chen Barrett, Janice Pursley and Alan Schuster and has published in prestigious journals such as Circulation, Blood and NeuroImage.

In The Last Decade

Wonkyung Byon

29 papers receiving 1.7k citations

Hit Papers

Apixaban: A Clinical Pharmacokinetic and Pharmacodynamic ... 2019 2026 2021 2023 2019 50 100 150 200
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Apixaban: A Clinical Pharmacokinetic and Pharmacodynamic Review
    2019 207 citations Wonkyung Byon, Samira M. Garonzik et al. Clinical Pharmacokinetics profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wonkyung Byon United States 17 1.1k 674 132 132 114 29 1.7k
Xavier Delavenne France 23 724 0.6× 386 0.6× 232 1.8× 113 0.9× 89 0.8× 105 1.6k
Sebastian Haertter Germany 15 2.1k 1.8× 1.2k 1.8× 263 2.0× 131 1.0× 156 1.4× 30 2.5k
Barbara Voith Germany 9 1.1k 1.0× 919 1.4× 160 1.2× 114 0.9× 64 0.6× 15 1.5k
Rebecca A. Boyd United States 21 1.4k 1.2× 800 1.2× 265 2.0× 241 1.8× 141 1.2× 34 2.4k
Jessie Wang United States 16 1.4k 1.3× 888 1.3× 196 1.5× 99 0.8× 116 1.0× 59 1.9k
Troy C. Sarich United States 24 956 0.8× 478 0.7× 315 2.4× 410 3.1× 128 1.1× 55 2.0k
Maximilian T. Lobmeyer United States 14 1.1k 1.0× 384 0.6× 146 1.1× 136 1.0× 231 2.0× 26 1.6k
Alan Schuster United States 14 763 0.7× 430 0.6× 82 0.6× 108 0.8× 43 0.4× 23 1.3k
Helen Kastrissios United States 19 403 0.4× 243 0.4× 112 0.8× 65 0.5× 129 1.1× 49 1.4k
Willy Roth Germany 17 1.4k 1.2× 870 1.3× 237 1.8× 286 2.2× 108 0.9× 23 2.3k

Countries citing papers authored by Wonkyung Byon

Since Specialization
Citations

This map shows the geographic impact of Wonkyung Byon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wonkyung Byon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wonkyung Byon more than expected).

Fields of papers citing papers by Wonkyung Byon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wonkyung Byon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wonkyung Byon. The network helps show where Wonkyung Byon may publish in the future.

Co-authorship network of co-authors of Wonkyung Byon

This figure shows the co-authorship network connecting the top 25 collaborators of Wonkyung Byon. A scholar is included among the top collaborators of Wonkyung Byon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wonkyung Byon. Wonkyung Byon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Byon, Wonkyung, et al.. (2024). Clinical Implications of Co‐administering Apixaban with Key Interacting Medications. Clinical Pharmacology in Drug Development. 13(9). 961–973. 1 indexed citations
2.
Banfield, Christopher, et al.. (2024). Population pharmacokinetic modeling of oral brepocitinib in healthy volunteers and patients with immuno‐inflammatory diseases. CPT Pharmacometrics & Systems Pharmacology. 13(4). 551–562. 3 indexed citations
3.
Byon, Wonkyung, Yogesh T. Patel, Vidya Perera, et al.. (2023). Evaluation of safety, pharmacokinetics, and pharmacodynamics of apixaban in pediatric subjects at risk of venous or arterial thrombotic disorder. CPT Pharmacometrics & Systems Pharmacology. 12(4). 500–512. 7 indexed citations
4.
Jamieson, M. J., Wonkyung Byon, Peter S. Gargalovic, et al.. (2022). Apixaban Use in Obese Patients: A Review of the Pharmacokinetic, Interventional, and Observational Study Data. American Journal of Cardiovascular Drugs. 22(6). 615–631. 8 indexed citations
5.
Cohen, Alexander T., et al.. (2021). Efficacy, Safety, and Exposure of Apixaban in Patients with High Body Weight or Obesity and Venous Thromboembolism: Insights from AMPLIFY. Advances in Therapy. 38(6). 3003–3018. 27 indexed citations
6.
Stanifer, John W., Sean D. Pokorney, Glenn M. Chertow, et al.. (2020). Apixaban Versus Warfarin in Patients With Atrial Fibrillation and Advanced Chronic Kidney Disease. Circulation. 141(17). 1384–1392. 95 indexed citations
7.
Garonzik, Samira M., et al.. (2019). The Effects of Clarithromycin on the Pharmacokinetics of Apixaban in Healthy Volunteers: A Single-Sequence Crossover Study. American Journal of Cardiovascular Drugs. 19(6). 561–567. 13 indexed citations
8.
9.
Byon, Wonkyung, Samira M. Garonzik, Rebecca A. Boyd, & Charles Frost. (2019). Apixaban: A Clinical Pharmacokinetic and Pharmacodynamic Review. Clinical Pharmacokinetics. 58(10). 1265–1279. 207 indexed citations breakdown →
10.
Byon, Wonkyung, Sunil Nepal, Alan Schuster, Andrew Shenker, & Charles Frost. (2018). Regional Gastrointestinal Absorption of Apixaban in Healthy Subjects. The Journal of Clinical Pharmacology. 58(7). 965–971. 36 indexed citations
11.
Vakkalagadda, Blisse, Charles Frost, Wonkyung Byon, et al.. (2016). Effect of Rifampin on the Pharmacokinetics of Apixaban, an Oral Direct Inhibitor of Factor Xa. American Journal of Cardiovascular Drugs. 16(2). 119–127. 82 indexed citations
12.
Chang, Ming, Zhigang Yu, Andrew Shenker, et al.. (2015). Effect of renal impairment on the pharmacokinetics, pharmacodynamics, and safety of apixaban. The Journal of Clinical Pharmacology. 56(5). 637–645. 131 indexed citations
13.
Dykstra, Kevin, Nitin Mehrotra, Christoffer W. Tornøe, et al.. (2015). Reporting guidelines for population pharmacokinetic analyses. Journal of Pharmacokinetics and Pharmacodynamics. 42(3). 301–314. 26 indexed citations
14.
15.
Frost, Charles, Sunil Nepal, Jessie Wang, et al.. (2013). Safety, pharmacokinetics and pharmacodynamics of multiple oral doses of apixaban, a factorXa inhibitor, in healthy subjects. British Journal of Clinical Pharmacology. 76(5). 776–786. 225 indexed citations
16.
17.
Upreti, Vijay, Jessie Wang, Yu Chen Barrett, et al.. (2013). Effect of extremes of body weight on the pharmacokinetics, pharmacodynamics, safety and tolerability of apixaban in healthy subjects. British Journal of Clinical Pharmacology. 76(6). 908–916. 209 indexed citations
18.
Chang, Cheng, Wonkyung Byon, Yifeng Lu, et al.. (2011). Quantitative PK–PD Model-Based Translational Pharmacology of a Novel Kappa Opioid Receptor Antagonist Between Rats and Humans. The AAPS Journal. 13(4). 565–575. 36 indexed citations
19.
Byon, Wonkyung, Danièle Ouellet, Marci L. Chew, et al.. (2010). Exposure‐Response Analyses of the Effects of Pregabalin in Patients With Fibromyalgia Using Daily Pain Scores and Patient Global Impression of Change. The Journal of Clinical Pharmacology. 50(7). 803–815. 12 indexed citations
20.
Byon, Wonkyung, Courtney V. Fletcher, & Richard C. Brundage. (2007). Impact of censoring data below an arbitrary quantification limit on structural model misspecification. Journal of Pharmacokinetics and Pharmacodynamics. 35(1). 101–116. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xavier Delavenne Breakdown of academic impact, for papers by Sebastian Haertter Breakdown of academic impact, for papers by Barbara Voith Breakdown of academic impact, for papers by Rebecca A. Boyd Breakdown of academic impact, for papers by Jessie Wang Breakdown of academic impact, for papers by Troy C. Sarich Breakdown of academic impact, for papers by Maximilian T. Lobmeyer Breakdown of academic impact, for papers by Alan Schuster Breakdown of academic impact, for papers by Helen Kastrissios Breakdown of academic impact, for papers by Willy Roth
Rankless by CCL
2026